在患有严重门功能障碍的患者中,同时进行跨apical transcatheter 大动脉和 mitra 门置换:初步经验
Jiawei Zhou1, Yuehuan Li1, JianGang Wang1
1Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.
General thoracic and cardiovascular surgery
|April 22, 2024
概括
使用J同时通过导管更换大动脉和 mitra 门是严重门功能障碍患者的可行选择. 这种方法在一小群患者中证明了100%的设备成功,没有30天的死亡率.
科学领域:
- 心血管外科心血管外科
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 同时通过导管切换中门 (VIV) 和大动脉门的切换是一个新兴的程序,记录的经验有限.
- 严重的大动脉和 mitra 门功能障碍往往需要复杂的手术干预.
研究的目的:
- 报告与同时进行跨吸管跨导管大动脉替换和中枢替换的初始经验.
- 评估这种结合方法的可行性和安全性,使用自扩展J.
主要方法:
- 八名患有严重的 mitrale 生物假体失败 (VIV) 和并发性大动脉疾病的患者同时接受了跨apical 植入.
- 在所有患者中,自扩张的J-门被用于两位心关和大动脉门的替换.
- 根据门学术研究联盟-2标准,评估了设备成功和并发症的程序.
主要成果:
- 100%的设备成功,没有与手术相关的并发症,如左心室外流通道阻塞或门迁移.
- 住院时间的平均长度为11.5天,没有30天的死亡率.
- 随访时间中位数为28.7个月,所有患者仍然活着,位于纽约心脏协会的I-II功能类,两位门均正常运作.
结论:
- 同时通过自扩展的J替换横管甲状腺和 mitra 膜是一种可行的和有效的替代传统的重复手术.
- 这种综合方法为患有严重的,联合的大动脉和中枢病的高风险患者提供了有前途的选择.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...


